ISSN: 0176-3679

Journal Home

Journal Guideline

Pharmacopsychiatry Q1 Unclaimed

Georg Thieme Verlag Germany

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pharmacopsychiatry is a journal indexed in SJR in Medicine (miscellaneous) and Psychiatry and Mental Health with an H index of 86. It has a price of 2417 €. It has an SJR impact factor of 0,943 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,943.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Pharmacology (medical) (Q2) Psychiatry and Mental Health (Q2)

Price

2417 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,943

SJR Impact factor

86

H Index

36

Total Docs (Last Year)

103

Total Docs (3 years)

1734

Total Refs

311

Total Cites (3 years)

91

Citable Docs (3 years)

2

Cites/Doc (2 years)

48.17

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

MMWR. Morbidity and mortality weekly report Q1
Annual Review of Public Health Q1
Annual Review of Clinical Psychology Q1
Journal of Thoracic Oncology Q1
Lancet Digital Health, The Q1

Compare this journals

Aims and Scope

Best articles by citations

Marked Increase of Venlafaxine Enantiomer Concentrations as a Consequence of Metabolic Interactions: A Case Report

Successful Treatment of Delusional Disorder of the Somatic Type or "Delusional Parasitosis" with Olanzapine

Heart-Rate Variability (HRV) in the ECG Trace of Routine EEGs: Fast Monitoring for the Anticholinergic Effects of Clozapine and Olanzapine?

Epidemiological Evidence for a Low Abuse Potential of Zolpidem

Fluvoxamine: Safety Profile in Extensive Post-Marketing Surveillance

Akathisia Masked by Hypokinesia

Critical evaluation of the effect of valerian extract on sleep structure and sleep quality - Pharmacopsychiatry 2000; 33: 47 - 53, by F. Donath et al -

Citalopram: an Interaction Study with Clomipramine in a Patient Heterozygous for CYP2D6 Genotype

A Comparison of the Effects of Clozapine and Olanzapine on the EEG in Patients with Schizophrenia

How Common is Violence in Schizophrenia despite Neuroleptic Treatment?

Effects of Hyperforin on the Fluidity of Brain Membranes

Uptake of Clozapine into HL-60 Promyelocytic Leukaemia Cells

SHOW MORE ARTICLES

Cytochrome P450 2D6 Deficiency and its Clinical Relevance in a Patient Treated with Risperidone

Suppression of Conditioned Fear by Administration of CRF Receptor Antagonist CP-154,526

A Case of Pharmacokinetic Interference in Comedication of Clozapine and Valproic Acid

Schizophrenic Psychosis: A Contraindication for Treatment of Hepatitis C with Interferon Alpha?

Hypothermia Developing during Neuroleptic Treatment

Permanent Pacing-Aid to Carry Out Long-term Lithium Therapy in Manic Patient With Symptomatic Bradycardia

Recruitment of Depressive Patients for a Controlled Clinical Trial in a Psychiatric Practice

Influence of Methodology on Outcomes of Randomised Clozapine Trials

Effects of Treatment with Chromium Picolinate on Peripheral Amino Acid Availability and Brain Monoamine Function in the Rat

Adjunctive Dopamine Agonists in Treatment-Resistant Bipolar II Depression: an Open Case Series

Neurophysiologic Tests during Antidepressive Treatment - an Exploratory Study

Does Lithium Exert an Independent Antisuicidal Effect?